@article{78917db84f024466acf645d3f47cfc64,
title = "Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor",
keywords = "Breast Neoplasms, Cell Line, Tumor, Cyclin-Dependent Kinase 4, Female, Fulvestrant, Humans, Phosphatidylinositol 3-Kinases, Signal Transduction",
author = "Leena Karimi and Alves, {Carla L.} and Terp, {Mikkel G.} and Martina Tuttolomondo and Neil Portman and Sidse Ehmsen and Johansen, {Lene E.} and Martin Bak and Elgene Lim and Ditzel, {Henrik J.}",
note = "Funding Information: This research was funded in part by grants from the Danish Cancer Society (to Henrik J. Ditzel), Health Insurance “Denmark” (to Henrik J. Ditzel), Academy of Geriatric Cancer Research (AgeCare) (to Henrik J. Ditzel), and Pink Tribute (to Henrik J. Ditzel). ",
year = "2023",
month = jun,
doi = "10.1002/cac2.12425",
language = "English",
volume = "43",
pages = "720--725",
journal = "Cancer Communications",
issn = "2523-3548",
publisher = "Wiley",
number = "6",
}